H.C. Wainwright analyst Emily Bodnar downgraded Arcellx (ACLX) to Neutral from Buy with an unchanged price target of $115 after Gilead (GILD) agreed to acquire the company for $115 per share in cash and one contingent value right of $5 per share. The acquisition is “not surprising” following the companies’ long-standing partnership, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACLX: